NYSE - Nasdaq Real Time Price USD

Bristol-Myers Squibb Company (BMY)

45.15 +0.30 (+0.66%)
As of 9:51 AM EDT. Market Open.
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for BMY

Recent News: BMY

View More
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases

Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
PR Newswire 3 hours ago
Repertoire pivot pays dividends with Bristol Myers deal

Repertoire pivot pays dividends with Bristol Myers deal
BioPharma Dive 7 hours ago
Bristol-Myers Squibb First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Bristol-Myers Squibb First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. 2 days ago
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals

The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Zacks 3 days ago
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma

CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
Business Wire 3 days ago
Beyond the Balance Sheet: What SWOT Reveals About Bristol-Myers Squibb Co (BMY)

Beyond the Balance Sheet: What SWOT Reveals About Bristol-Myers Squibb Co (BMY)
GuruFocus.com 3 days ago

Q1 2024 Bristol-Myers Squibb Co Earnings Call
Thomson Reuters StreetEvents 3 days ago
Bristol Myers Squibb stock tumbles on cost-cutting initiative

Bristol Myers Squibb stock tumbles on cost-cutting initiative
Yahoo Finance Video 3 days ago
AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge

AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
Investor's Business Daily 3 days ago
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX

Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
Zacks 3 days ago
Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions

Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions
Benzinga 3 days ago

Update: Bristol-Myers Squibb Swings to Q1 Non-GAAP Loss, Revenue Rises; Provides 2024 Guidance -- Shares Fall
PREMIUM
MT Newswires 3 days ago
View More

Related Tickers

PFE Pfizer Inc.
25.72
+1.26%
 
ABBV AbbVie Inc.
160.97
+0.85%
 
MRK Merck & Co., Inc.
131.43
+0.18%
 
GILD Gilead Sciences, Inc.
66.20
+1.19%
 
JNJ Johnson & Johnson
146.87
+0.50%
 
AZN AstraZeneca PLC
76.08
+1.21%
 
BIIB Biogen Inc.
214.90
+2.87%
 
LLY Eli Lilly and Company
733.95
+0.06%
 
AMGN Amgen Inc.
273.94
+1.46%
 
SNY Sanofi
49.39
+0.53%